Epocrates Inc. is a leading physician platform for essential clinical content, practice tools and health industry engagement at the point of care. The Epocrates network consists of well over one million healthcare professionals including approximately 330,000, or more than 50% of, U.S. physicians. Epocrates’ portfolio features top-ranked medical applications including the industry’s #1 used mobile drug reference, which provides convenient, point-of-care access to information such as dosing, drug interactions, pricing and insurance coverage for thousands of brand, generic and over-the-counter drugs. The features available through our unique platform are referenced multiple times per day and help healthcare professionals make more informed prescribing decisions, improve workflow and enhance patient safety. We offer our products on major U.S. mobile platforms including Apple iOS, Android and BlackBerry.
![Epocrates logo](https://files.capedge.com/S-1/0001047469-10-006501/g653810.jpg)
Company profile
Ticker
EPOC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
943326769
Latest filings (excl ownership)
15-12B
Securities registration termination
25 Mar 13
25-NSE
Exchange delisting
12 Mar 13
8-K
Completion of Acquisition or Disposition of Assets
12 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 13
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Mar 13
10-K
2012 FY
Annual report
11 Mar 13
DEFA14A
Additional proxy soliciting materials
6 Mar 13
DEFM14A
Proxy related to merger
11 Feb 13
PREM14A
Preliminary proxy related to merger
25 Jan 13
8-K
Other Events
16 Jan 13